MTN-017 A Phase 2 Randomized Study of Tenofovir & Truvada^
MTN-017 A Phase 2 Randomized Study of Tenofovir & Truvada^
MTN-017 替诺福韦的 2 期随机研究
批准号：
8556706
负责人：
金额：
$5.0万
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
关键词：
Acquired Immunodeficiency SyndromeCenters for Disease Control and Prevention (U.S.)CommitCommunitiesHIVMucous MembraneNational Institute of Allergy and Infectious DiseasePhasePopulationPrevention ResearchRandomizedRecruitment ActivityResearch ActivitySexually Transmitted DiseasesTenofovirThailandVaginaclinical research sitecohortdesignmenmicrobicidephase 2 studypreventrectalsextransmission processtruvada
中文摘要
翻译
杀微生物剂是设计用于阴道或直肠粘膜的产品，目的是预防或至少显着减少性传播感染（包括HIV）的获得。NIAID和CDC仍然致力于预防研究，以减少人类免疫缺陷病毒（HIV）的传播和获得性免疫缺陷综合症（AIDS）的负担。
英文摘要
Microbicides are products that are designed to be applied to the vaginal or rectal mucosa with the intent of preventing or at least significantly reducing the acquisition of sexually transmitted infections including HIV. The NIAID and the CDC remain committed to prevention research to reduce the transmission of human immunodeficiency virus (HIV) and the burden of acquired immunodeficiency syndrome (AIDS).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文